Forum Systems and NASCO announce strategic Generative AI partnership
Technology leaders to jointly offer LLM-powered applications for healthcare payers
"We have nearly 40 years of exclusive service to some of the largest health insurers across the nation," said
The partnership's first joint offerings tackle three major pain points for payers: security, contract management and benefits management. Three modules of QuantumSim™ — QS SecureGPT, QS ContractsGPT and QS BenefitsGPT — are among the first AI-powered, payer-specific products on the market to usher in the next generation of payer technology.
QS SecureGPT is a foundational component to an organization's use of generative AI (GenAI). It protects large language model (LLM) applications through obfuscation, guardrails and observability, allowing enterprises to leverage LLMs without fearing for their private data or reputation.
QS ContractsGPT ingests and analyzes contracts with a powerful natural language processing (NLP) engine, which provides rapid document discovery, summarization and information extraction, enabling ease of interaction with critical documents that are often difficult to effectively manage. The solution also enables business, legal, and procurement teams to chat with their document through public and private LLM integration.
QS BenefitsGPT standardizes benefits data with knowledge graphs, allowing product analysts, customer service agents, members, and other stakeholders to quickly extract relevant information. Integration with powerful public and private LLMs enables a unified natural language interface for rapid deployment and interface training.
Recent Gartner® research — "Quick Answer: How Can
NASCO and Forum Systems are harnessing the power of AI in a responsible, value-driven way to unlock healthcare data, pioneer innovative products, engage members and providers, and enable a more efficient healthcare ecosystem.
"When we saw payers immediately shutting off public LLMs, we knew the potential productivity gains were too great to ignore, but the obstacles were big too," said
QS SecureGPT and QS ContractsGPT are currently commercially available, and QS BenefitsGPT is in a late development stage with early-adopter health insurers. These initial AI-backed offerings are tackling some of the biggest challenges that payers face. The Forum Systems and NASCO partnership will focus on understanding how GenAI and related technologies can continue to create improved efficiencies and provide value for payers.
For more information about the partnership and the three modules of QuantumSim™ (QS SecureGPT, QS ContractsGPT and QS BenefitsGPT), contact
Source: Gartner, Quick Answer: How Can
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the
About Forum Systems
Forum Systems is leading the Enterprise GenAI revolution. Forum's patent-pending QuantumSim™, together with Forum Sentry, mitigate the unpredictable nature of LLMs through integration with corporate APIs, ensuring LLM output is truthful and accurate. Used by some of the largest global companies for building intelligent business workflows, Forum's suite of products provides unique, industry-leading solutions that allow enterprises to reinvent themselves with GenAI.
About NASCO
NASCO, a wholly-owned subsidiary of the largest health insurer in
View original content to download multimedia:https://www.prnewswire.com/news-releases/forum-systems-and-nasco-announce-strategic-generative-ai-partnership-301991153.html
SOURCE Forum Systems
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AVCON RECEIVES FAA STC FOR HONEYWELL AEROSPACE REPLACEMENT EGPWS ON BOMBARDIER AND LEARJET AIRCRAFT
- Immersive Wisdom Awarded Contract in Support of U.S. Army Next Generation Command and Control (NGC2)
- High Winds, Dry Conditions Mean PG&E May Need to Proactively Turn Off Power for Safety Wednesday Evening in Portions of Twenty-Nine Counties
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share